Mirum Pharmaceuticals, Inc. (MIRM)
97.02
+1.53
(+1.60%)
USD |
NASDAQ |
May 19, 13:31
Mirum Pharmaceuticals Research and Development Expense (Quarterly) : 97.84M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BridgeBio Pharma, Inc. | 126.64M |
| BioMarin Pharmaceutical, Inc. | 178.80M |
| Insmed, Inc. | 209.48M |
| Ionis Pharmaceuticals, Inc. | 210.17M |
| AnaptysBio, Inc. | 33.86M |